Cargando…
Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367944/ https://www.ncbi.nlm.nih.gov/pubmed/32419097 http://dx.doi.org/10.1007/s13555-020-00390-y |
_version_ | 1783560517897420800 |
---|---|
author | Pinter, Andreas Mielke, Nicole Malisiewicz, Bartosz Kaufmann, Roland König, Anke |
author_facet | Pinter, Andreas Mielke, Nicole Malisiewicz, Bartosz Kaufmann, Roland König, Anke |
author_sort | Pinter, Andreas |
collection | PubMed |
description | INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starting in childhood. However, little information is available on prevalence data and the clinical management of PedPso by paediatricians. METHODS: A total of 191 questionnaires were sent out to paediatricians regarding their management of PedPso, with a focus on prevalence, diagnosis, initiation of therapies, screening for comorbidities and collaboration with dermatologists. Of these, 95 (49.7%) were returned and evaluated anonymously. RESULTS: Only about one-half of the responding paediatricians reported being certain in their diagnosis of PedPso, even though they regularly see moderate-to-severely affected patients. The questionnaire revealed that there are clear differences in the general management of PedPso if the paediatrician is not certain of the diagnosis of psoriasis. Compared to paediatricians certain of their diagnosis, those who are uncertain less frequently perform whole-body inspection, screen for relevant comorbidities, such as psoriasis arthritis, metabolic syndrome or mental disorders, and prescribe the use of topical or systemic therapies. No responding paediatrician reported the use of modern systemic therapies, such as biologicals, even in severely affected children. The majority of respondents rated their cooperation with dermatologists as good. CONCLUSION: The certainty of the diagnosis, the use of system therapies and the screening for comorbidity could improve the care of PedPso through targeted training of paediatricians and intensified interdisciplinary cooperation with dermatologist. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13555-020-00390-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7367944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-73679442020-07-22 Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey Pinter, Andreas Mielke, Nicole Malisiewicz, Bartosz Kaufmann, Roland König, Anke Dermatol Ther (Heidelb) Original Research INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starting in childhood. However, little information is available on prevalence data and the clinical management of PedPso by paediatricians. METHODS: A total of 191 questionnaires were sent out to paediatricians regarding their management of PedPso, with a focus on prevalence, diagnosis, initiation of therapies, screening for comorbidities and collaboration with dermatologists. Of these, 95 (49.7%) were returned and evaluated anonymously. RESULTS: Only about one-half of the responding paediatricians reported being certain in their diagnosis of PedPso, even though they regularly see moderate-to-severely affected patients. The questionnaire revealed that there are clear differences in the general management of PedPso if the paediatrician is not certain of the diagnosis of psoriasis. Compared to paediatricians certain of their diagnosis, those who are uncertain less frequently perform whole-body inspection, screen for relevant comorbidities, such as psoriasis arthritis, metabolic syndrome or mental disorders, and prescribe the use of topical or systemic therapies. No responding paediatrician reported the use of modern systemic therapies, such as biologicals, even in severely affected children. The majority of respondents rated their cooperation with dermatologists as good. CONCLUSION: The certainty of the diagnosis, the use of system therapies and the screening for comorbidity could improve the care of PedPso through targeted training of paediatricians and intensified interdisciplinary cooperation with dermatologist. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13555-020-00390-y) contains supplementary material, which is available to authorized users. Springer Healthcare 2020-05-18 /pmc/articles/PMC7367944/ /pubmed/32419097 http://dx.doi.org/10.1007/s13555-020-00390-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Pinter, Andreas Mielke, Nicole Malisiewicz, Bartosz Kaufmann, Roland König, Anke Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title | Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title_full | Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title_fullStr | Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title_full_unstemmed | Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title_short | Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey |
title_sort | management of paediatric psoriasis by paediatricians: a questionnaire-based survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367944/ https://www.ncbi.nlm.nih.gov/pubmed/32419097 http://dx.doi.org/10.1007/s13555-020-00390-y |
work_keys_str_mv | AT pinterandreas managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey AT mielkenicole managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey AT malisiewiczbartosz managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey AT kaufmannroland managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey AT koniganke managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey |